Rep. Kevin Hern Sells Shares of IQVIA Holdings Inc. (NYSE:IQV)

Posted by Stanley Muller on Sep 29th, 2026

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in IQVIA stock on September 14th. The trade occurred in the Representative’s “HERN FAMILY FOUNDATION” account.

Representative Kevin Hern also recently made the following trade(s):

Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
Sold $15,001 – $50,000 in shares of STERIS (NYSE:STE) on 9/15/2026.
Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
Sold $15,001 – $50,000 in shares of Devon Energy (NYSE:DVN) on 9/14/2026.

IQVIA Stock Performance

IQV stock opened at $271.01 on Tuesday. IQVIA Holdings Inc. has a 1 year low of $154.50 and a 1 year high of $277.40. The stock has a market capitalization of $44.61 billion, a price-to-earnings ratio of 33.62, a PEG ratio of 2.31 and a beta of 1.18. The company has a debt-to-equity ratio of 2.18, a quick ratio of 0.71 and a current ratio of 0.71. The stock’s fifty day moving average is $250.32 and its two-hundred day moving average is $203.63.

IQVIA (NYSE:IQV – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The medical research company reported $3.15 EPS for the quarter, topping the consensus estimate of $3.03 by $0.12. The business had revenue of $4.37 billion during the quarter, compared to analyst estimates of $4.30 billion. IQVIA had a net margin of 8.10% and a return on equity of 30.25%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.81 earnings per share. IQVIA has set its FY 2026 guidance at 12.800-13.000 EPS. On average, research analysts predict that IQVIA Holdings Inc. will post 11.56 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on IQV shares. Morgan Stanley increased their price objective on IQVIA from $240.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, September 17th. Deutsche Bank Aktiengesellschaft set a $240.00 price target on IQVIA in a research report on Thursday, July 9th. Robert W. Baird raised their price target on IQVIA from $252.00 to $287.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Royal Bank Of Canada increased their target price on shares of IQVIA from $221.00 to $247.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Finally, BMO Capital Markets raised their target price on shares of IQVIA from $210.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $253.25.

Read Our Latest Research Report on IQV

Insider Buying and Selling

In other IQVIA news, insider Bhavik Patel sold 1,855 shares of IQVIA stock in a transaction on Friday, July 31st. The shares were sold at an average price of $235.27, for a total transaction of $436,425.85. Following the completion of the sale, the insider owned 1,348 shares of the company’s stock, valued at $317,143.96. This trade represents a 57.91% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Keriann Cherofsky sold 558 shares of the company’s stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $245.21, for a total transaction of $136,827.18. Following the completion of the transaction, the insider directly owned 2,989 shares in the company, valued at $732,932.69. This trade represents a 15.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 15,581 shares of company stock worth $3,796,021 over the last ninety days. 1.70% of the stock is currently owned by corporate insiders.

Institutional Trading of IQVIA

Several institutional investors and hedge funds have recently added to or reduced their stakes in IQV. Korea Investment CORP acquired a new position in IQVIA in the 2nd quarter worth approximately $13,918,000. Deutsche Bank AG acquired a new stake in shares of IQVIA in the second quarter worth $143,074,000. BlackRock Inc. acquired a new position in IQVIA during the second quarter valued at $2,811,292,000. Focus Partners Advisor Solutions LLC purchased a new stake in IQVIA in the 2nd quarter worth about $976,000. Finally, Pallas Capital Advisors LLC acquired a new stake in IQVIA during the 2nd quarter worth about $1,552,000. 89.62% of the stock is owned by institutional investors and hedge funds.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About IQVIA

(Get Free Report)

IQVIA Holdings Inc (NYSE: IQV) is a global provider of technology, analytics and contract research services for the life sciences industry. The company helps pharmaceutical, biotechnology and medical device organizations develop products, manage clinical trials, understand healthcare markets and improve commercial performance.

IQVIA’s offerings include clinical research and trial management, real-world data and evidence, healthcare analytics, technology platforms, consulting, and commercial services such as sales support and patient engagement.